MedPath

The Effects of sodium butyrate supplementation on obesity

Phase 2
Recruiting
Conditions
Obesity.
Obesity due to excess calories
E66.0
Registration Number
IRCT20190303042905N3
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Body mass index (BMI) between 30-40
Both of genders female and male
Age between 18-60 years old

Exclusion Criteria

Unwillingness to participate in the study
Kidney diseases
liver failure
heart failure
rheumatic diseases
diabetes
malignancies, and gastrointestinal diseases
Taking weightloss drugs and following a weight loss diet
History of bariatric surgery
Smoking
Pregnancy, lactation, menopause

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression level of AdipoR1& R2. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.;Gene expression level of AMPK. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.;Gene expression level of UCP 2 & 3. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.
Secondary Outcome Measures
NameTimeMethod
Serum levels of hsCRP. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ELISA kit.;Atherogenic index of plasma(AIP). Timepoint: Before the intervention and two months after the intervention. Method of measurement: based on formula: AIP=log??triglycerides /high density lipoprotein?.
© Copyright 2025. All Rights Reserved by MedPath